Pharmaceutical Technology, MSc, Study notes of Pharmacy

Download Pharmaceutical Technology, MSc and more Study notes Pharmacy in PDF only on Docsity! Programme approval 2006/07 PROGRAMME APPROVAL FORM SECTION 1 – THE PROGRAMME SPECIFICATION 1. Programme title and designation Pharmaceutical Technology 2. Final award Award Title Credit value ECTS equivalent Any special criteria MSc Pharmaceutical Technology 180 90 N/A 3. Nested awards Award Title Credit value ECTS equivalent Any special criteria N/A N/A N/A N/A N/A 4. Exit awards Award Title Credit value ECTS equivalent Any special criteria PG Cert Biosciences 60 30 Modules - any combination to a minimum value of 60 credits PG Dip Biosciences 120 90 Modules - any combination to a minimum value of 120 credits 5. Level in the qualifications framework M 6. Attendance Full-time Part-time Distance learning Mode of attendance   N/A Minimum length of programme 12 months 24 months N/A Maximum length of programme 3 years 6 years N/A 7. Awarding institution/body King’s College London 8. Teaching institution King’s College London 9. Proposing department Department of Pharmacy 10. Programme organiser and contact details Dr. M Thanou Department of Pharmacy Franklin-Wilkins Building Waterloo Campus Extension. 4807 maya.thanou@kcl.ac.uk 11. UCAS code (if appropriate) NA 12. Relevant QAA subject benchmark/ professional and statutory body guidelines There are no specific benchmark statements for this Masters programme. However, some relevant statements can be found in the QAA Subject Benchmark Statements for Pharmacy: http://www.qaa.ac.uk/crntwork/benchmark/phase2/pharm acy.htm 13. Date of production of specification 02 June 2005 (March 2007 Implementation CF) PAF originally approved by QA&AA: 31 May 2007 PAF approved for 2008/9 by QA&AA: 22nd September 2008 PAF Approved for 2009/10 by QA&AA: 3rd September 2009 PAF modified by ASQ re: exit awards: 8 April 2010 PAF finalised for 2011/12: 23 August 2011 PAF modified by QAS for 2012/13: 2nd March 2012 PAF finalised for 2014/15: 2 March 2015 Programme approval 2006/07 14. Date of programme review 2017/18 16. Educational aims of the programme • Provide an appropriate learning environment for a post-graduate programme that enables the delivery of high quality teaching and research methods • Provide an intellectual challenge to students at the postgraduate level • Encourage the student to be capable of working confidently and adopting a mature, professional and safe attitude to their work • Encourage the student to develop independent and self critical learning to maximise their own potential • Increase the depth of the student’s knowledge, technical and transferable skills in an integrated manner to enhance their current and future roles • Facilitate students to develop their transferable skills that include advanced study practices, precision and clarity in verbal and written communication, numeracy, team work and decision making • Enhance critical, analytical problem-solving skills, evidence-based decision making skills and the use of information technology • Establish a firm foundation for the pursuit of professional qualifications, and continuing professional development in the pharmaceutical industry, or healthcare sector • Enhance competence in numerical methods used in the pharmaceutical sciences • Provide an appreciation of the underlying science of biopharmaceutics and drug delivery • Provide an advanced understanding of drug absorption, distribution, metabolism, excretion and pharmacokinetics • Facilitate students to develop an advanced understanding of the principles of drug analysis by chromatographic and spectroscopic and other pharmacopoeial methods • Provide comprehensive understanding of the drug development process and the role of regulatory agencies • Facilitate students to develop the ability to critically review the scientific literature, critically analyse information, synthesise and summarise conclusions • Provide a comprehensive understanding of formulation and production of medicines, including the assessment and control of quality of manufactured products 17. Educational objectives of the programme/programme outcomes The programme provides opportunities for students to develop and demonstrate knowledge and understanding and skills in the following areas: • Subject knowledge • Pharmaceutical-related cognitive abilities and skills • Pharmaceutical-related practical skills • Transferable key skills All areas are defined in detail below Knowledge and understanding The programme provides a knowledge and understanding of the following: Subject Knowledge • A knowledge and understanding of: o Drug Delivery These are achieved through the following teaching/learning methods and strategies: The modules are taught by subject specialists, including visiting professionals. PAF originally approved by QA&AA: 31 May 2007 PAF approved for 2008/9 by QA&AA: 22nd September 2008 PAF Approved for 2009/10 by QA&AA: 3rd September 2009 PAF modified by ASQ re: exit awards: 8 April 2010 PAF finalised for 2011/12: 23 August 2011 PAF modified by QAS for 2012/13: 2nd March 2012 PAF finalised for 2014/15: 2 March 2015 Programme approval 2006/07 Generic/transferable skills: 28. Communicate ideas effectively both orally and in writing 29. Analyse and appraise the literature in a critical manner 30. Critically assess issues of sample selection, accuracy, precision and uncertainty, in the collection and analysis of data 31. Utilise appropriate numerical and statistical problem-solving skills 32. Utilise information technology resources (information retrieval) 33. Critically appraise and evaluate in a reasoned fashion 34. Work independently and as part of a team 35. Manage time and resources to complete all aspects of the programme These are achieved through the following teaching/learning methods and strategies: Generic/transferable skills detailed in points 28 – 35 are developed in a contextualised manner throughout the programme. These skills are highlighted using problem solving, practical laboratory sessions, IT, information retrieval, CAL, poster and presentation skills. These skills are enhanced during tutorials, seminars, laboratory classes, workshop tutorials and coursework assignments. Assessment: All generic/transferable skills are assessed through the various assessment strategies adopted throughout the programme. A variety of assessment methods are used to assess transferable key skills. Skill 28 is assessed via oral presentations and workshop seminars. Skills 29 – 32 are assessed via various coursework assignments within the different modules, the research project and workshop seminars; including CAL. Skills 32 - 34 are assessed during the project, problem-solving assignments, practical reports and the final written dissertation. Skill 35 is developed throughout the programme by adhering to deadlines and completing the written dissertation. 18. Statement of how the programme has been informed by the relevant subject benchmark statement(s)/professional, regulatory and statutory body guidelines There are no specific benchmark statements for this programme; however, attention has been placed upon the QAA benchmarking statements for pharmacy so that the programme and curriculum are informed by the specific subject knowledge, abilities and skills outlined in these statements 19. Programme structure and award requirements (a) numbers of introductory, core, compulsory and optional modules to be taken in each year of the programme with related credit values MSc 5 core modules (180 Credits in total).* see below PAF originally approved by QA&AA: 31 May 2007 PAF approved for 2008/9 by QA&AA: 22nd September 2008 PAF Approved for 2009/10 by QA&AA: 3rd September 2009 PAF modified by ASQ re: exit awards: 8 April 2010 PAF finalised for 2011/12: 23 August 2011 PAF modified by QAS for 2012/13: 2nd March 2012 PAF finalised for 2014/15: 2 March 2015 Programme approval 2006/07 PGDip modules any combination to a minimum value of 120 credits PGCert modules any combination to a minimum value of 60 credits (b) range of credit levels permitted within the programme 7 (c) maximum number of credits permitted at the lowest level 180 MSc, 120 Dip, 60 Cert (d) minimum number of credits required at the highest level 180 MSc, 120 Dip, 60 Cert (e) progression and award requirements (if different from the standard) None (f) maximum number of credits permitted with a condoned fail (core modules excluded) As all modules are core a condoned fail is not permitted (g) are students permitted to take a substitute module, as per regulation A3? No (h) other relevant information to explain the programme structure MSc in Pharmaceutical Technology Students taking the MSc part-time over two years will be required to take and pass the core modules (120 credits) in the order specified below: Year 1 Principles of Drug Delivery and Disposition Drug Delivery: Liquid Dosage Forms and Microbiology Year 2 Principles of Analytical Techniques, Numerical Methods and Regulatory Affairs Drug Delivery: Solid Dosage Forms Research Project Students are required to submit the research project in the second year of study * Students normally take research module Research project (7BBPM014) as this is the laboratory research project but can take Literature Review Project (7BBPM019) at the discretion of the Department if this is impractical PAF originally approved by QA&AA: 31 May 2007 PAF approved for 2008/9 by QA&AA: 22nd September 2008 PAF Approved for 2009/10 by QA&AA: 3rd September 2009 PAF modified by ASQ re: exit awards: 8 April 2010 PAF finalised for 2011/12: 23 August 2011 PAF modified by QAS for 2012/13: 2nd March 2012 PAF finalised for 2014/15: 2 March 2015 Programme approval 2006/07 Programme Structure Title Credit level Credit value Status (I, Cr, Cp, O) for each type of programme Progression Assessment Single Joint Major/ minor Single Joint Major/ minor 7BBPM010 Principles of Drug Delivery and Disposition 7 30 Cr Yes Examination, Coursework 7BBPM011 Principles of Analytical Techniques, Numerical Methods and Regulatory Affairs 7 30 Cr Yes Examination, Coursework 7BBPM017 Drug Delivery: Solid Dosage Forms 7 30 Cr Yes Examination, Coursework 7BBPM018 Drug Delivery: Liquid Dosage Forms and Microbiology 7 30 Cr Yes Examination, Coursework 7BBPM014 Research Project 7 60 CrCp* Yes Written Thesis, Oral Presentation 7BBPM019 Literature Review Project 7 60 CrCp* No Research Review Paper Poster presentation, research records, student performance 20. Marking criteria All modules will be marked in accordance with the Schools marking criteria where such exist or else in accordance with the Colleges general marking criteria. PAF originally approved by QA&AA: 31 May 2007 PAF approved for 2008/9 by QA&AA: 22nd September 2008 PAF Approved for 2009/10 by QA&AA: 3rd September 2009 PAF modified by ASQ re: exit awards: 8 April 2010 PAF finalised for 2011/12: 23 August 2011 PAF modified by QAS for 2012/13: 2nd March 2012 PAF finalised for 2014/15: 2 March 2015